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Abstract We show here that preincubation of pancreatic islet 
cells with a-toeopherol significantly improves their resistance to 
toxic doses of nitric oxide (NO). No protection was afforded by 
other antioxidants uch as vitamin C or glutathione-monoethyl 
ester. The pathway of NO induced islet cell death involves DNA 
damage and excessive activation of poly(ADP-ribose)poly- 
merase leading to irreversible depletion of intraeellular NAD +. 
a-Tocopherol was found to interfere at early steps of this path- 
way, by preventing the occurrence of DNA strand breaks. This 
indicates that a-tocopherol directly interacts with NO or its reac- 
tive intermediates. We conclude that a-tncopherol is not only part 
of the cellular defence system against oxygen radicals but also 
protects eukaryotie cells from NO toxicity. 
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In type 1 (insulin-dependent) diabetes, ROI as well as NO are 
thought to contribute to islet fl cell destruction [9,11,12]. In 
vitro, NO was identified as the most potent islet-toxic product 
of inflammatory macrophages [13]. These findings led us to 
search for possible endogenous scavengers of undesired NO 
toxicity. In an earlier study we analysed several potent hydro- 
philic antioxidants and the enzymes uperoxide dismutase and 
catalase for their ability to protect islet cells from NO induced 
cell death. None of the compounds tested improved islet cell 
survival which indicated that the oxygen radical defence system 
of eukaryotic ells may not be involved in prevention of unde- 
sired NO toxicity. During the continuation of these studies we 
now have identified one member of the cellular oxidants de- 
fence system which provides protection from NO toxicity in 
islet cells, c~-tocopherol. 
2. Materials and methods 
I. Introduction 
Nitric oxide (NO) has been identified as a potent and plei- 
otropic mediator of numerous physiological and immunologi- 
cal reactions. Although the picture of NO functions is far from 
complete, it is now clear that this radical accounts for the 
activity of endothelium-derived r laxing factor, acts as neuro- 
transmitter, prevents platelet aggregation and is a major de- 
fence molecule of immune cells against parasites, tumour cells 
and mycobacteria [1,2]. 
Due to its radical nature NO interacts with several constitu- 
ents of cells, including heme groups, iron sulfur clusters of 
enzymes, sulfhydryl residues and DNA [1,2]. While some of 
these actions serve physiological or immune defence purposes, 
an undesired effect is the damage of bystander cells and of the 
NO producing cell itself [3,4]. 
This situation is reminiscent of the role of oxygen radical 
intermediates (ROI) in eukaryotic ells. Oxygen radicals, on the 
one hand, serve as physiological mediators, such as in NFkB 
activation, and as immune defence molecules [5,6]. On the other 
hand, ROI display undesired toxicity towards the cells of the 
body. Several mechanisms have been identified which provide 
protection from ROI toxicity in eukaryotic ells, these include 
ROI inactivating enzymes, as well as hydrophilic and lipophilic 
antioxidants [7,8]. 
Recent data suggest hat NO may equal or surpass oxygen 
radicals in contributing to tissue damage during inflammation 
[3,4,9]. Moreover, vascular damage in long-term diabetic ani- 
mals could be partly prevented by the administration f oxygen 
radical scavengers but was fully suppressed in rats receiving an 
inhibitor of NO formation [10]. 
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2.1. Islet cells 
Pancreatic slet cells were isolated from Wistar rats (provided from 
our own breeding colony) by injection of a collagenase solution in the 
pancreatic duct (Serva GmbH, Heidelberg, Germany; 0.37 U/mg, 1.5 
mg/ml in Hank's balanced salt solution (HBSS; Gibco-Europe, Hei- 
delberg, Germany)) as described [14]. After 35 rain of incubation at 
37°C the islets were enriched by centrifugation f the dispersed pancre- 
atic tissue on a Ficoll gradient (Ficol1400, Pharmacia GmbH, Freiburg, 
Germany). Subsequently, the islets were dissociated in single cells by 
treatment with 2 mg/ml trypsin (Boehringer-Mannheim, Mannheim, 
Germany) in Ca 2+- and Mg2+-free HBSS (Gibco). For the experiments 
the islet cells were resuspended in modified RPMI 1640 (Gibco) with 
a reduced glucose concentration f 4 mM and supplemented with 25 
mg/l ampicillin, 120 mg/1 penicillin, 270 mg/1 streptomycin (Serva), 
1 mM sodium pyruvate, 2 mM L-glutamine, 10 ml/l non-essential amino 
acids (100×; Gibco), 2 g/l NaHCO3, 2.38 g/1 HEPES (Serva) and 10% 
fetal calf serum (FCS; Gibco). 
2.2. Antioxidants 
RRR-~-tocopherol (ct-tocopherol) was a kind gift of Henkel KGaA 
(Dtisseldorf, Germany), vitamin C (ascorbic acid) was purchased from 
Sigma and glutathione-monoethyl ester (GME) was purchased from 
Bachem Biochemica GmbH (Heidelberg, Germany). Stock solutions of 
the compounds were freshly prepared in modified RPMI 1640 (vitamin 
C, GME) or ethanol (~-tocopherol) before each experiment. The final 
concentration f ethanol in the samples with 0t-tocopherol never ex- 
ceeded 1% and control experiments showed no detectable effects of 1% 
ethanol on cell viability or DNA integrity. Also, ethanol did not inter- 
fere with NO toxicity in islet cells. 
2.3. Nitric oxide cytotoxieity assay 
For the analysis of nitric oxide induced islet cell toxicity 2 × 10 4 islet 
cells were seeded in triplicates in 120/11 modified RPMI 1640 per well 
of l/2-area flat-bottom microtiter plates (Costar, Cambridge, MA, 
USA). The cells were incubated for different time intervals with various 
concentrations of ct-tocopherol or other potentially protective com- 
pounds and exposed to NO for 18 h. In some samples the ~-tocopherol 
was removed by washing the samples three times with fresh culture 
medium before the exposure to NO. NO was generated chemically by 
the addition of 0.45 mM sodium nitroprusside (sodium pentacyano- 
nitrosylferrate(II); Merck, Darmstadt, Germany) which releases NO 
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during decomposition. Rhodanese (EC 2.8.1.1; 8 U/well; Sigma, Deis- 
enhofen, Germany) and Na2S203 (5 mM; Merck) were added to scav- 
enge cyanide ions potentially released uring the decomposition of
sodium nitroprusside [15]. The viability of the islet cells was evaluated 
by the Trypan blue exclusion assay at the end of the incubation periods. 
To determine the percentage of dead cells at least 200 cells per well were 
counted [15]. 
To analyze DNA damage islet cells were cultivated in Lab-Tec cham- 
ber slides (Nunc, Naperville, IL, USA) until adherence and exposed to 
the various experimental reatments. Then the cells were air-dried, fixed 
in acetone (10 min) and subjected to the in situ nick translation proce- 
dure as described previously [16]. Briefly, 50 Jzl of the nick translation 
mixture (4 U/100 ,ul Kornberg polymerase; EC 2.7.7.7; Boehringer- 
Mannheim; 3 A,M biotinylated dUTP; 3/,tM each dGTP, dCTP, dATP; 
50 mM Tris-HC1, pH 7.5; 5 mM MgC12; 0.1 mM dithiothreitol) were 
added on the fixed cells for 9 min at room temperature. To block 
non-specific antibody binding, the cells were incubated for 10 min in 
phosphate buffered saline with 0.1% thimerosal and 10% FCS. The 
biotinylated UTP, incorporated by polymerase-activity at sites of 
DNA damage, was detected by the peroxidase reaction (Vectastain-Kit, 
Camon, Wiesbaden, Germany) using diaminobenzidine as substrate. 
Nuclei with DNA strand breaks appeared brown. At least 100 cells per 
chamber were evaluated microscopically and the percentage of cells 
with stained nuclei was determined. 
2.4. Statistics 
Differences between mean values were analyzed by Student's t-test, 
two-sided. 
3. Results 
When freshly isolated pancreatic islet cells were exposed to 
NO generated by sodium nitroprusside, plasma membrane lysis 
was seen only after several hours of incubation (Fig. 1A). For 
analysis of possible protective activity, ~-tocopherol was added 
to islet cell cultures 6 h prior to addition of the NO donor 
sodium nitroprusside. In the absence of ~-tocopherol, NO- 
induced islet cell lysis was 65 + 9% (mean + S.D.). Significant 
protection from NO toxicity was observed in the presence of 
10-1000/JM ~-tocopherol (Fig. 1B). Near-maximal effect was 
already seen at 10/~M (47% protection from cell lysis) with only 
minor increased protection with 100-fold higher ~-tocopherol 
levels (60% protection at 1 mM). 
The protective ffect was not further improved by extending 
the time of contact between ~-tocopherol and islet cells. As 
shown in Fig. 2A near-maximal effects of ~-tocopherol were 
already reached with 3 h of preincubation. ~-Tocopherol was 
still partially protective when added immediately prior to the 
NO donor (at 0 h; Fig. 2A). This rapid action of exogenous 
~-tocopherol allowed us to analyse whether ~-tocopherol ex- 
erted its effect on early or late steps of NO toxicity. To reach 
significant protection the addition of ~-tocopherol could be 
delayed for 2 h, but when given 4 h after the addition of NP 
cell lysis was not reduced (Fig. 2B). 
To exclude a possible direct interaction between NO and 
~-tocopherol islet cells were preincubated with 100/zM ~-toco- 
pherol. After 6 h, the vitamin-containing medium was removed 
by washing the samples with fresh culture medium. Then NP 
was added and the lysis of the islet cells was determined after 
18 h. As shown in Table 1, preincubation with ~-tocopherol 
reduced islet cell lysis from 64.1% to 44.5%. The protection 
almost reached the level which was achieved when ~-tocopherol 
was present 6 h before and during the 18 h incubation period 
with NP (41.7%). 
Since DNA strand breaks were observed previously by us as 
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Fig. 1. (A) Kinetics of NO induced islet cell lysis. Sodium nitroprusside 
(NP; 0.45 mM) was added to the islet cells and cell lysis was determined 
by the Trypan blue exclusion method after various incubation periods. 
(B) Dose-dependent protection of islet cells from NO induced lysis by 
~-tocopherol. Increasing doses of ~-tocopherol were added to the islet 
cells 6 h prior to the addition of sodium nitroprusside (NP; 0.45 mM). 
Islet cell lysis was determined after 18 h of incubation. Data show 
mean + S.D. from 3 experiments. **P < 0.001 compared to the samples 
without ~-tocopherol. 
crucial early events in the destruction of islet cells by NO [17], 
we determined whether ~-tocopherol would prevent DNA 
damage. As shown in Fig. 3, the percentage of cells with recog- 
nizeable DNA damage after 4 and 18 h of incubation with the 
NO donor was strongly reduced in the presence of 100 ,uM 
~-tocopherol. 
Finally we compared the potential of ~-tocopherol, vitamin 
C and glutathione to prevent NO toxicity. Significant protec- 
tion was only seen for ~-tocopherol (Fig. 4). Various combina- 
tions of the compounds did not provide better protection than 
~-tocopherol alone (data not shown). 
4. Discussion 
The data show for the first time that ~-tocopherol protects 
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Fig. 2. Effect of ~-tocopherol addition before or after initiation of NO 
exposure, -Tocopherol (100/IM) was added to the islet cells at various 
time points before (A) or after (B) the addition of sodium nitroprusside 
(NP; 0.45 mM). Control samples were incubated with sodium nitro- 
prusside alone (o). The lysis of the islet cells was determined after 18 
h of incubation in the presence of sodium nitroprusside ( ). Data show 
mean + SD from 3 experiments. *P < 0.01, **P < 0.001 compared to 
the sample without the addition of ~-tocopherol at0 h. 
eukaryotic ells from NO cytotoxicity. Previously, pancreatic 
islet cells have been found to be highly susceptible to NO 
released by inflammatory macrophages or chemical NO donors 
[14,15,17,18]. Islet cell destruction by NO was significantly sup- 
pressed in the presence of -> 10/~M ~-tocopherol while slight 
or no protection was afforded by vitamin C or glutathione- 
monoethyl ester, respectively. The failure of vitamin C or gluta- 
thione to significantly improve islet cell survival supports the 
concept that oxygen radical scavengers are not effective in 
preventing NO toxicity [15,19,20]. We conclude that antioxi- 
dants in general do not mediate defence against NO toxicity, 
with ~-tocopherol as an exception. 
What is the mechanism of the protective action of ~-tocophe- 
rol? The possibility of a direct scavenging of exogenous NO by 
~z-tocopherol present in the culture medium was ruled out in 
experiments in which ~-tocopherol was washed out before the 
60 
~ 5O 
"G 40 
e- ,  
"~ 30 
E 20 
I 
z 10 
0 
/ / /  
/ / /  
/ / /  
/ / /  
/ / /  / / " /  
/ / /1  
/ / /  -~ 
/ / /  / / /  
/ / /  
/ / /  
/ / /  
/ / /  
/ / /  
/ / /  
4h 18h 
Duration of NP-exposure 
Fig. 3. Reduction of NO induced DNA damage in islet cells by ~- 
tocopherol. Islet cells were preincubated in the absence (hatched bars) 
or in the presence (open bars) of 100/IM ~-tocopherol for 6 h before 
the addition of sodium nitroprusside (NP; 0.45 raM). The percentage 
of cells with DNA damage was determined by the in situ nick transla- 
tion technique after 4 h and 18 h of incubation with the NO donor. Data 
show mean + S.D. from 3 experiments. *P < 0.01, **P < 0.001 com- 
pared to the samples treated with NP alone. 
addition of the NO donor sodium nitroprusside. Even under 
these conditions ~-tocopherol exerted a protective ffect on 
islet cells. This observation implies that islet cells have the 
ability to take up sufficient amounts of~-tocopherol to improve 
their defence potential against radicals. Recent studies had 
shown that NO mediated lysis of islet cells is a process which 
takes at least 4-6 h for completion [15]. The kinetic studies 
performed indicate that c~-tocopherol exerts its protective ac- 
tion during the first hours of exposure to NO. Since sodium 
nitroprusside was found to release NO at a low rate in aqueous 
solutions [21] it can be expected that islet cell toxic concentra- 
tions of the NO will be reached only after several hours of 
incubation with the NO donor. This may explain the partial 
protective ffect of c~-tocopherol even when the vitamin was 
added immediately prior to sodium nitroprusside. 
The pathway of NO induced cell lysis has been determined 
by us recently [17,22]. In the early stage it involves DNA strand 
breaks followed by activation of the DNA repair enzyme 
Table 1 
Effect of preincubation with c~-tocopherol on NO-induced islet cell lysis 
Treatment Islet cell lysis (%) 
Control c~-Tocopherol incubation period 
-6hto0h  -6hto  18h 
None 11.0 + 2.2 13.0 + 1.0 12.0 + 2.2 
Nitroprusside 
(0.45 mM) 64.1 _+ 2.2 44.5 + 2.6* 41.7 _+ 2.7* 
Islet cells were preincubated for 6 h in the absence or presence of 100 
/IM ~z-tocopherol. Then in a set of samples the ~-tocopherol was re- 
moved by washing the samples. NP (0.45 mM) was added at t = 0 and 
the incubation was continued for 18 h in the absence or presence of 
~-tocopherol. Islet cell lysis was determined by the Trypan blue exclu- 
sion assay and expressed as percent of positive cells. Data show 
mean + S.D. from 6 experiments. 
*P < 0.001 compared to the controls treated with NP alone. 
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Fig. 4. Potential of ~-tocopherol, vitamin C and glutathione-monoethyl 
ester to prevent NO induced islet cell lysis. Islet cells were incubated 
with various doses of ~-tocopherol (c¢-Toc.), vitamin C (Vit. C) and 
glutathione-monoethyl ester (GME) 6 h prior to the addition of the NO 
donor sodium nitroprusside (0.45 mM). Islet cell lysis was determined 
after 18 h of exposure to sodium nitroprusside. Controls treated with 
the NO donor alone were lysed to 65.2 + 8.8%. Data show mean + S.D. 
from 3 experiments. 
poly(ADP-ribose)polymerase. Th  excessive synthesis of poly- 
ADP-ribose from NAD ÷ causes rapid depletion of intracellular 
NAD ÷ stores and subsequent cell lysis. This NAD + depletion 
pathway has been suggested previously to account for strepto- 
zotocin toxicity in islet cells and for oxygen radical toxicity in 
various cell types including islet cells [23]. Other known toxic 
actions of NO, such as the inhibition of the electron transfer 
chain in mitochondria, of aconitase and glyceraldehyde-3- 
phosphate dehydrogenase or the release of intracellular iron do 
not appear to be involved. Direct evidence for dominance of 
this mechanism of cell death came from the analysis of cells 
with a disrupted poly(ADP-ribose)polymerase gene [24]. Pro- 
tection from cell death by c~-tocopherol therefore must be due 
to interference with the NAD + depletion pathway. DNA dam- 
age is an early step of this pathway and indeed we found a 
strong reduction of NO induced DNA strand breaks in the 
presence of e-tocopherol. We therefore conclude that c~-toco- 
pherol suppresses toxicity of NO towards nuclear DNA and 
thereby prevents induction of the NAD + depletion pathway. 
This conclusion is supported by earlier studies in bacteria 
where ~-tocopherol was found to suppress the mutagenic, i.e. 
DNA damaging, action of NO [25]. Interestingly, this study of 
NO mutagenicity in bacteria lso showed little protection by 
other antioxidants beside c~-tocopherol. The only other effec- 
tive compound was fl-carotene [25]. NO-induced alterations of 
mammalian DNA resemble those seen in cancers of the colon, 
liver and lungs [26]. Thus, like oxygen radicals, NO is a poten- 
tial mutagen and may be a factor contributing tocarcinogene- 
sis. 
It will be difficult to determine in which compartment of
eukaryotic cells and by which mechanism c~-tocopherol b ocks 
the damaging effect of NO on DNA. In this context a report 
by de Groot et al. is of interest showing that in a lipophilic 
solvent c~-tocopherol is oxidized to its quinone derivative when 
in contact with NO gas [27]. Furthermore, it was found that 
~-tocopherol in low-density lipoprotein is oxidized by per- 
oxynitrite, a product of the reaction between itric oxide and 
superoxide [28]. These findings demonstrate hat ~-tocopherol 
may directly interact with NO or NO-derived reactive interme- 
diates. 
The protective ffect of c~-tocopherol was found to be dose- 
dependent, but even at a level of 1 mM exogenous ~-tocopherol 
did not completely prevent NO-induced islet cell death. Possi- 
bly, islet cells do not accumulate sufficient quantities of the 
vitamin. On the other hand, NO toxicity may also affect com- 
partments of the cell with little ~-tocopherol content. Finally, 
NO displays a wide range of chemical reactivities and under 
certain conditions resembles the positively charged nitro- 
sonium ion or the negatively charged nitroxyl anion rather than 
the neutral radical [29,30]. ~-Tocopherol may not interfere with 
all of these NO species. 
Our findings are very likely relevant to the situation in vivo. 
NO has been shown to be generated at high levels by the 
inducible NO synthase at sites of inflammation [3,4,31,32]. The 
administration f inhibitors of NO synthases has been found 
to decrease or prevent issue damage in a large number of 
chronic inflammatory diseases including immune complex 
glomerulonephritis, graft versus host disease and arthritis [3,4]. 
A role of NO in the pathogenesis of type I diabetes has been 
suggested [33,34], and the administration f large doses of c~- 
tocopherol prevented spontaneous autoimmune diabetes in the 
NOD mouse [35] while only minor effects were seen in the BB 
rat diabetes model [36,37]. Taken together these data imply that 
~-tocopherol participates not only in the cellular oxygen radical 
defence system but also mediates protection from undesired 
NO toxicity, c~-Tocopherol thus qualifies as a member of the 
cellular NO defence system, when the majority of compounds 
remain to be identified. 
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